[{"Assets_0_Q1_USD":244188000.0,"CommonStockSharesOutstanding_0_Q1_shares":26751588.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-43221000.0,"NetIncomeLoss_1_Q1_USD":-46130000.0,"StockholdersEquity_0_Q1_USD":214140000.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180502"}]